Scott H Kollins
Overview
Explore the profile of Scott H Kollins including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
175
Citations
3883
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Victoria L, Oberlin L, Ilieva I, Jaywant A, Kanellopoulos D, Mercaldi C, et al.
Neuropsychopharmacology
. 2024 Oct;
50(2):472-479.
PMID: 39358543
Post-COVID-19 cognitive deficits are common, persistent, and disabling. Evidence on effective treatments is limited. The goal of this study was to investigate the efficacy of a digital intervention to reduce...
2.
Liman C, Schein J, Wu A, Huang X, Thadani S, Childress A, et al.
BMC Psychiatry
. 2024 Sep;
24(1):618.
PMID: 39285361
Background: The objectives of this study were to examine the association of psychiatric comorbidities and patient characteristics with treatment change and response as well as to assess the association between...
3.
Davis N, Lerebours R, Aiello R, Carpenter K, Compton S, Franz L, et al.
J Child Psychol Psychiatry
. 2024 Sep;
66(2):214-224.
PMID: 39227035
Background: Autism commonly co-occurs with attention-deficit/hyperactivity disorder (ADHD), but less is known regarding how ADHD symptoms impact the early presentation of autism. This study examined early behavioral characteristics of a...
4.
Stamatis C, Heusser A, Simon T, Alailima T, Kollins S
Transl Psychiatry
. 2024 Aug;
14(1):328.
PMID: 39128918
AKL-T01 is a digital therapeutic (DTx) that targets attention by generating conflict at dynamically updated difficulty levels during a multitasking game. Clinical trials support AKL-T01's efficacy in attention-deficit/hyperactivity disorder (ADHD),...
5.
Marryat J, Davis N, Lerebours R, Carpenter K, Compton S, Eichner B, et al.
J Autism Dev Disord
. 2024 Jul;
PMID: 38995481
Purpose: Early detection and intervention are associated with improved outcomes for autistic children. Thus, it is important to understand factors influencing early screening tools designed to detect autism. This study...
6.
Stamatis C, Farlow D, Mercaldi C, Suh M, Maple A, Savarese A, et al.
Npj Ment Health Res
. 2024 Jun;
3(1):30.
PMID: 38898133
Inattention symptoms represent a key driver of functional impairment in ADHD and often persist into adolescence and adulthood, underscoring a need for novel treatments targeting attentional control. We evaluated AKL-T01-a...
7.
Flannery J, Hinshaw S, Kollins S, Stamatis C
BMC Public Health
. 2024 Apr;
24(1):1195.
PMID: 38685016
Background: Attention-deficit/hyperactivity disorder (ADHD) remains underdiagnosed and undertreated in girls. Inattentive symptoms, often predominant in girls with ADHD, represent a key driver of impairment and often persist into adulthood. AKL-T01...
8.
Cutler A, Kollins S, Brams M, Corliss M, Oh C, Braeckman R, et al.
Front Psychiatry
. 2024 Apr;
15:1310483.
PMID: 38566957
Objective: To evaluate treatment responder rate using the Attention-Deficit/Hyperactivity Disorder Rating Scale-5 (ADHD-RS-5) score based on optimized dose level of serdexmethylphenidate/dexmethylphenidate (SDX/d-MPH) and changes in ADHD severity in children (aged...
9.
Lunsford-Avery J, Carskadon M, Kollins S, Krystal A
J Am Acad Child Adolesc Psychiatry
. 2024 Mar;
64(2):276-289.
PMID: 38484795
Objective: Few studies have characterized the nature of sleep problems among adolescents with attention-deficit/hyperactivity disorder (ADHD) using polysomnography (PSG). Additionally, although adolescents with ADHD and adolescents with sleep disturbances display...
10.
Patel R, Chan K, Palmer E, Valko M, Guruswamy G, Ker S, et al.
Schizophr Res
. 2023 Sep;
260:191-197.
PMID: 37683509
Background And Hypothesis: Schizophrenia and comorbid substance use disorders (SUDs) are associated with poor treatment outcomes but differences between the associations of different SUDs with clinical outcomes are poorly characterized....